The government shutdown imposes immediate bottlenecks for the chemical industry. TSCA work has come to a halt, and the EPA backlog of reviewing chemical manufacturers' requests to make or import new chemicals is growing. Disruption to innovation pipelines can be costly. Fingers crossed this is stale news and it’s business as usual in Washington. – Traci Purdum, editor-in-chief (P.S. please take the anonymous R&D poll in the lead article).
